SXL
IBB icon

Summit X LLC’s iShares Biotechnology ETF IBB Stock Holding History

Summit X LLC’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-21,944
Closed -$2.67M – 219
2018
Q3 		$2.67M Buy
21,944
+8,680
+65% +$1.02M 1.31% 18
2018
Q2 		$1.45M Sell
13,264
-1,518
-10% -$162K 0.81% 31
2018
Q1 		$1.57M Buy
14,782
+12,736
+622% +$1.41M 0.94% 28
2017
Q4 		$218K Sell
2,046
-25,686
-93% -$2.75M 0.14% 166
2017
Q3 		$3.08M Buy
27,732
+972
+4% +$104K 2.04% 10
2017
Q2 		$2.76M Buy
+26,760
New +$2.64M 1.97% 9

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
N
Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return

Summit X LLC's IBB Position: Q4 2018 in Review

Summit X LLC sold out of iShares Biotechnology ETF (IBB) in Q4 2018, closing a stake of 21,944 shares — an estimated $2.67M sold.

Summit X LLC first reported a position in IBB in Q2 2017 and held it in 6 quarters. The position peaked at $3.08M in Q3 2017. 649 funds tracked by Wall St. Rank hold IBB as of Q4 2018.

  • Summit X LLC reported no remaining iShares Biotechnology ETF position as of Q4 2018 after selling out during the quarter.
  • Summit X LLC sold 21,944 iShares Biotechnology ETF shares in Q4 2018, an estimated $2.67M.
  • Summit X LLC first reported a position in iShares Biotechnology ETF in Q2 2017 and held it in 6 quarters.
  • Summit X LLC's iShares Biotechnology ETF position peaked at $3.08M in Q3 2017.
  • 649 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2018.

Based on Summit X LLC's 13F filing for Q4 2018, filed 13 Feb 2019.